Newly Licensed Monitored Intensively by Committee for Safety of Medicines (CSM) which reports to MHRA (Medicines and Healthcare Products Regulatory Agency) Usually reviewed after 2 YEARS If a drug is labelled with this, it means it is monitored EVEN MORE INTENSIVELY